Mark Mercola

Stanford University, Palo Alto, CA 
"Mark Mercola"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cheng J, Tsuda M, Okolotowicz K, et al. (2021) Small-molecule probe reveals a kinase cascade that links stress signaling to TCF/LEF and Wnt responsiveness. Cell Chemical Biology
McKeithan WL, Feyen DAM, Bruyneel AAN, et al. (2020) Reengineering an Antiarrhythmic Drug Using Patient hiPSC Cardiomyocytes to Improve Therapeutic Potential and Reduce Toxicity. Cell Stem Cell
Levitas A, Muhammad E, Zhang Y, et al. (2020) A Novel Recessive Mutation in SPEG Causes Early Onset Dilated Cardiomyopathy. Plos Genetics. 16: e1009000
Briganti F, Sun H, Wei W, et al. (2020) iPSC Modeling of RBM20-Deficient DCM Identifies Upregulation of RBM20 as a Therapeutic Strategy. Cell Reports. 32: 108117
Feyen DAM, McKeithan WL, Bruyneel AAN, et al. (2020) Metabolic Maturation Media Improve Physiological Function of Human iPSC-Derived Cardiomyocytes. Cell Reports. 32: 107925
Bruyneel AAN, Colas AR, Karakikes I, et al. (2019) AlleleProfileR: A versatile tool to identify and profile sequence variants in edited genomes. Plos One. 14: e0226694
Halver J, Wenzel K, Sendker J, et al. (2019) Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn? Frontiers in Pharmacology. 10: 1357
Hurtado C, Safarova A, Smith M, et al. (2019) Disruption of NOTCH signaling by a small molecule inhibitor of the transcription factor RBPJ. Scientific Reports. 9: 10811
Hnatiuk A, Mercola M. (2019) Stars in the Night Sky: iPSC-Cardiomyocytes Return the Patient Context to Drug Screening. Cell Stem Cell. 24: 506-507
Seeger T, Shrestha R, Lam CK, et al. (2018) A Premature Termination Codon Mutation in MYBPC3 Causes Hypertrophic Cardiomyopathy via Chronic Activation of Nonsense-Mediated Decay. Circulation
See more...